(Q33986226)

English

Type I IFN is a powerful mucosal adjuvant for a selective intranasal vaccination against influenza virus in mice and affects antigen capture at mucosal level.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811645%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Type I IFN is a powerful mucosal adjuvant for a selective intranasal vaccination against influenza virus in mice and affects antigen capture at mucosal level (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811645%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811645%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Filippo Belardelli

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811645%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Enrico Proietti

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811645%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Irene Canini

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811645%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Simona Puzelli

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811645%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Paola Sestili

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811645%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Massimo Venditti

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811645%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Massimo Spada

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811645%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Isabella Donatelli

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811645%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

language of work or name

0 references

publication date

1 April 2005

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811645%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811645%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811645%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

2994-3004

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811645%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811645%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Rapid recovery in mice after combined nasal/oral immunization with killed respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

The pulmonary environment promotes Th2 cell responses after nasal-pulmonary immunization with antigen alone, but Th1 responses are induced during instances of intense immune stimulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

Mucosal CD8alpha+ DC, with a plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

Role of interferons and other cytokines in the regulation of the immune response.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

IFN-alpha/beta enhances BCR-dependent B cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

Type I interferons enhance production of IFN-gamma by NK cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

Induction of bystander T cell proliferation by viruses and type I interferon in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

Type I interferons keep activated T cells alive

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

Regulation by interferon alpha of immunoglobulin isotype selection and lymphokine production in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

Type I interferons produced by dendritic cells promote their phenotypic and functional activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

The nature of the principal type 1 interferon-producing cells in human blood

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

Natural interferon alpha/beta-producing cells link innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

Maturation, activation, and protection of dendritic cells induced by double-stranded RNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

Dynamics of macrophage cell populations during murine pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

Parenteral vaccination against influenza does not induce a local antigen-specific immune response in the nasal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

The role of nasopharyngeal lymphoid tissue

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

Isolation and characterization of mouse nasal-associated lymphoid tissue

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

Influence of intravenous anesthesia on mucosal and systemic antibody responses to nasal vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

Roles of anti-hemagglutinin IgA and IgG antibodies in different sites of the respiratory tract of vaccinated mice in preventing lethal influenza pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

Visualization of in vivo olfactory uptake and transfer using fluorescein dextran

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

Macrophages present pinocytosed exogenous antigen via MHC class I whereas antigen ingested by receptor-mediated endocytosis is presented via MHC class II.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

Mucosally induced immunoglobulin E-associated inflammation in the respiratory tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

A murine model of pulmonary damage induced by lipopolysaccharide via intranasal instillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

A nasal whole-cell pertussis vaccine induces specific systemic and cross-reactive mucosal antibody responses in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

Roles of innate and adaptive immunity in respiratory mycoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

based on heuristic

inferred from DOI database lookup

A method for the large scale production of potent interferon preparations.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

based on heuristic

inferred from DOI database lookup

Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.12.006

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2004.12.006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811645%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811645%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33986226&oldid=1644658572"